The aim of this study was to investigate the role of paclitaxel on RAB family of genes in primary breast cancer cell lines. The cancer breast cells obtained from 40 women during mastectomy were used to address this issue.
INTRODUCTION
In the metabolism of neoplasm cells, processes involving division and growth play an important role. It has been reported that alterations in gene expression involved in the cell cycle were also characteristic of an increased activity of genes associated in cell proliferation and growth. These changes usually correlate with a decreased expression of genes that control growth, division and transcription processes in the cells. Oncogenes play a very important role in the transformation of normal cells to neoplastic cells. A significant number of these genes encode signaling proteins within the cell.
Some of these code factors influence cellular growth (sis, int) and growth factor receptors (erb-B, fms). In this group, there are known genes which code transcription factors (myb, myc, jun, fos), kinases (src,yes, abl, raf, mos), GTP binding proteins (ha-ras, ki-ras, n-ras) (1) .
Some of these genes cause the transformation from normal cells to neoplastic cells when mutation in their structure occurs. BRCA1 belongs to the suppressor genes group, which is an activator of the transcription process, involved mainly in the DNA repairing system (2) . The genes that belong to this group can inhibit or activate cell growth and proliferation in 2 ways. One of them inhibits transformation processes when they are not damaged by mutations. The normal function of these genes stops cell proliferation. P53 codes protein responsible for phosphorylation products of different genes (3) . It plays a crucial role in controlling the cell cycle by activating more than 30 genes (4,5). P-53 activates genes encoding proteins which can inhibit apoptosis. This protein stops the cell cycle in the G1 and G2 phase, which can enable DNA repairing. MDM-2 is the main protein that causes the decrease of p-53 level. MYC protein is responsible for the increased level of p53 and ARF. The active form of P53 can be released from the MDM/P53 complex (1). The higher expression of these genes activates proliferation processes. The mentioned genes (RAB, ACT, MYC, JUN, FOS) can activate faster growth, division of cells and transformation processes.
MATERIALS
The cancer cells were obtained from breast tissues of 40 women with histopathologically confirmed breast cancer. The group included patients with intraductal breast cancer -lesions in I or II advancement level by TNM classification and G1-G2 by Bloom classification. (tumor size up to 2.0 cm without metastases to lymph nodes). There patients were not administered any cytostatic drugs before surgery. The primary cultures were conducted in 25 cm 2 plastic containers at RPMI medium with 10% fetal bovine serum (FBS SIGMA), at standard conditions (37°C, 5% CO 2 , 90% humidity of the air).
Paclitaxel in 60 ng/ml and 300 ng/ml doses was administered to these cultures after achieving concentration of the cells 10 000/ml. The cytostatic concentrations were calculated in relation to therapeutic doses of paclitaxel applied in polytherapy in patients with breast cancer. The control culture was a suspension of the breast cancer cells without the administration of cytostatic treatment. To these cultures 5% DMSO was administered. The experiments were conducted in three independent trials for all mentioned groups of cultures.
Analysis was related to RAB family of genes : RAB3D, RAB5B, RAB5C, RAB7, RAB7L1,   RAB9P1, RAB10. RAB11A,  RAB311B, RAB13, RAB18, RAB22A, RAB23, RAB26,   RAB27A, RAB27B, RAB28, RAB30, RAB31, RAB33A, RAB3D6, RAB 38, RABL2B .
METHODS
After an incubation period of 72 hours with two doses of paclitaxel, the cultures were This mix was incubated at 42 ° C for 2.5 hours. In reverse transcription, the reaction cDNA containing labeled 32 P cytidine was estimated. Such received and purified cDNA was hybridized on the array. The Sigma-Genosis array contained sequences of oncogenes on the ground. cDNA was hybridized with the array in the hybridization chamber at 65° C for a period of 13 hours. After purifying the array and removing unconnected fragments of cDNA the ground was dried on a sterile blotting and placed in a cassette with a radiosensitive ground to collect the activity from points of the array (Screen Imaging K -Bio Rad) for 24
hours. After radiation of the radiosensitive ground, using a high resolution scanner it was scanned (Molecular Imager FX -BioRad) to estimate the picture of the array. Activities from the subsequent points of the array were normalized with the expression level of E. coli-B genes localized in control points. Statistic analysis was conducted by using program Statistica 6.0.
RESULTS
Analysis showed that in a group of cells where paclitaxel was administered at a dose of 60 ng/ml it caused statistically significant increase expression RAB family of genes in comparison to the control group. In the group where paclitaxel was administered at a dose of 300 ng/ml, a statistically significant decrease expression of the genes coding oncogenes was observed in comparison to thecontrol group.
There was a statistically significant correlation between the gene expression of the control group and both mentioned primary breast cell cultures after the administration of paclitaxel (P<0.001). This protein induces deacetylation of histone proteins and inhibition of transcription processes (34) . DAXX, joined with H2a, H2b, H3 and H4 histones, also with histone deacetylase -a basal factor, participates in repression of transcription (35) . Nonphosphorylated form of 70 kDa Daxx participates in inhibition of transcription due to cooperation with histon deacetylase, DEK proteins and histone coplex (36) . The direction of these activities is probably dependent on post-transcriptional modification. In some cases it can increase the production of the same gene.
Oncogenes belong to transcriptor factors that are AP-1 encoded by JUN family genes. The AP-1 Group consist of cFOS proteins creating JUN complexes. AP-1 cooperates with transcriptor factors: ATF-2, NFAT. They participate in the proliferation and transformation processes. Activation of AP1 is strictly connected with the cooperation of P38.
P38 which exists in some isoforms (37) .
RAB proteins are small GTP-ases. They belong to oncogenes coding products interacting with proteins located on the inner surface of the cell membrane (38) . Their expression is regulated by NF-E2. This factor also regulates activity of beta tubulin -a protein cooperating with paclitaxel. Paclitaxel can accelerate transcription of genes ranking the RAB family. Production of these genes inhibits activity of proteins connected with microtubules and the cytoskeletal system of the cell, formed by actin. They control the cell cycle and intracellular transport in cytoplasm. In the nucleus, they participate in forming nucleosomes and organize the mitotic spindle. They also play a crucial role in the activation of extracellular antigens (39) .
Rab27A is associated with invasive and metastatic potential of human breast cancer cell development. The over expression of Rab27A protein redistributed the cell cycle and increased the invasive and metastatic abilities in breast cancer cells both in vitro and in vivo.
We also certified that Rab27A bestowed the invasive and metastatic phenotypes on breast The signaling and in vitro phenotypic consequences of Rab11a expression and function were studied. Transfection of DN-Rab11a increased Erk1/2 activation downstream of EGF, but exerted no effect on the AKT pathway. Expression of DN-Rab11a inhibited MCF10A proliferation by 50-60%, and also inhibited anchorage-dependent colonization.
Notably, DN-Rab11a transfection increased motility toward EGFR ligands. The data provides a first demonstration that Rab11a modulates EGFR recycling, and promotes the proliferation but inhibits the motility of an immortal breast line, consistent with the DCIS phenotype (41).
Once candidate genes are identified, we perform functional genomics by manipulating levels in normal and tumor cells using RNAi or transfection, and assessing a battery of cellular functions including proliferation, anti-apoptosis, loss of contact inhibition, changes in cell signaling or transcriptional profiles, anchorage-independent growth, and in vivo tumor growth. We have successfully used this approach to identify the RAB25 gene that has been implicated in the progression and aggressiveness of ovarian and breast cancers (42) . with raf/erk leads to p65 nuclear factor kB mediated antiapoptosis involing c-IAP2.
